 | • レポートコード：MRC2-11QY07618 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は代謝型グルタミン酸受容体7のグローバル市場について調査・分析したレポートです。種類別（JBPOS-0101、PGT-117、ADX-71743、その他）市場規模、用途別（全般性不安障害、乳児けいれん、てんかん重積状態、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別代謝型グルタミン酸受容体7の競争状況、市場シェア ・世界の代謝型グルタミン酸受容体7市場：種類別市場規模 2015年-2020年（JBPOS-0101、PGT-117、ADX-71743、その他） ・世界の代謝型グルタミン酸受容体7市場：種類別市場規模予測 2021年-2026年（JBPOS-0101、PGT-117、ADX-71743、その他） ・世界の代謝型グルタミン酸受容体7市場：用途別市場規模 2015年-2020年（全般性不安障害、乳児けいれん、てんかん重積状態、その他） ・世界の代謝型グルタミン酸受容体7市場：用途別市場規模予測 2021年-2026年（全般性不安障害、乳児けいれん、てんかん重積状態、その他） ・北米の代謝型グルタミン酸受容体7市場分析：米国、カナダ ・ヨーロッパの代謝型グルタミン酸受容体7市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの代謝型グルタミン酸受容体7市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の代謝型グルタミン酸受容体7市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの代謝型グルタミン酸受容体7市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Addex Therapeutics Ltd、Aevi Genomic Medicine Inc、Bio-Pharm Solutions Co Ltd、Pragma Therapeutics SAS ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Metabotropic Glutamate Receptor 7 Market
The global Metabotropic Glutamate Receptor 7 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Metabotropic Glutamate Receptor 7 Scope and Market Size
Metabotropic Glutamate Receptor 7 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metabotropic Glutamate Receptor 7 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Metabotropic Glutamate Receptor 7 market is segmented into
JBPOS-0101
PGT-117
ADX-71743
Others
Segment by Application, the Metabotropic Glutamate Receptor 7 market is segmented into
Generalized Anxiety Disorder
Infantile Spasm
Status Epilepticus
Others
Regional and Country-level Analysis
The Metabotropic Glutamate Receptor 7 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Metabotropic Glutamate Receptor 7 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Metabotropic Glutamate Receptor 7 Market Share Analysis
Metabotropic Glutamate Receptor 7 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Metabotropic Glutamate Receptor 7 business, the date to enter into the Metabotropic Glutamate Receptor 7 market, Metabotropic Glutamate Receptor 7 product introduction, recent developments, etc.
The major vendors covered:
Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Bio-Pharm Solutions Co Ltd
Pragma Therapeutics SAS
…
1 Study Coverage
1.1 Metabotropic Glutamate Receptor 7 Product Introduction
1.2 Market Segments
1.3 Key Metabotropic Glutamate Receptor 7 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Type
1.4.2 JBPOS-0101
1.4.3 PGT-117
1.4.4 ADX-71743
1.4.5 Others
1.5 Market by Application
1.5.1 Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Application
1.5.2 Generalized Anxiety Disorder
1.5.3 Infantile Spasm
1.5.4 Status Epilepticus
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Metabotropic Glutamate Receptor 7 Market Size, Estimates and Forecasts
2.1.1 Global Metabotropic Glutamate Receptor 7 Revenue 2015-2026
2.1.2 Global Metabotropic Glutamate Receptor 7 Sales 2015-2026
2.2 Global Metabotropic Glutamate Receptor 7, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Metabotropic Glutamate Receptor 7 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Metabotropic Glutamate Receptor 7 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Metabotropic Glutamate Receptor 7 Competitor Landscape by Players
3.1 Metabotropic Glutamate Receptor 7 Sales by Manufacturers
3.1.1 Metabotropic Glutamate Receptor 7 Sales by Manufacturers (2015-2020)
3.1.2 Metabotropic Glutamate Receptor 7 Sales Market Share by Manufacturers (2015-2020)
3.2 Metabotropic Glutamate Receptor 7 Revenue by Manufacturers
3.2.1 Metabotropic Glutamate Receptor 7 Revenue by Manufacturers (2015-2020)
3.2.2 Metabotropic Glutamate Receptor 7 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Metabotropic Glutamate Receptor 7 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 7 Revenue in 2019
3.2.5 Global Metabotropic Glutamate Receptor 7 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Metabotropic Glutamate Receptor 7 Price by Manufacturers
3.4 Metabotropic Glutamate Receptor 7 Manufacturing Base Distribution, Product Types
3.4.1 Metabotropic Glutamate Receptor 7 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Metabotropic Glutamate Receptor 7 Product Type
3.4.3 Date of International Manufacturers Enter into Metabotropic Glutamate Receptor 7 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Metabotropic Glutamate Receptor 7 Market Size by Type (2015-2020)
4.1.1 Global Metabotropic Glutamate Receptor 7 Sales by Type (2015-2020)
4.1.2 Global Metabotropic Glutamate Receptor 7 Revenue by Type (2015-2020)
4.1.3 Metabotropic Glutamate Receptor 7 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Metabotropic Glutamate Receptor 7 Market Size Forecast by Type (2021-2026)
4.2.1 Global Metabotropic Glutamate Receptor 7 Sales Forecast by Type (2021-2026)
4.2.2 Global Metabotropic Glutamate Receptor 7 Revenue Forecast by Type (2021-2026)
4.2.3 Metabotropic Glutamate Receptor 7 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Metabotropic Glutamate Receptor 7 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Metabotropic Glutamate Receptor 7 Market Size by Application (2015-2020)
5.1.1 Global Metabotropic Glutamate Receptor 7 Sales by Application (2015-2020)
5.1.2 Global Metabotropic Glutamate Receptor 7 Revenue by Application (2015-2020)
5.1.3 Metabotropic Glutamate Receptor 7 Price by Application (2015-2020)
5.2 Metabotropic Glutamate Receptor 7 Market Size Forecast by Application (2021-2026)
5.2.1 Global Metabotropic Glutamate Receptor 7 Sales Forecast by Application (2021-2026)
5.2.2 Global Metabotropic Glutamate Receptor 7 Revenue Forecast by Application (2021-2026)
5.2.3 Global Metabotropic Glutamate Receptor 7 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Metabotropic Glutamate Receptor 7 by Country
6.1.1 North America Metabotropic Glutamate Receptor 7 Sales by Country
6.1.2 North America Metabotropic Glutamate Receptor 7 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Metabotropic Glutamate Receptor 7 Market Facts & Figures by Type
6.3 North America Metabotropic Glutamate Receptor 7 Market Facts & Figures by Application
7 Europe
7.1 Europe Metabotropic Glutamate Receptor 7 by Country
7.1.1 Europe Metabotropic Glutamate Receptor 7 Sales by Country
7.1.2 Europe Metabotropic Glutamate Receptor 7 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Metabotropic Glutamate Receptor 7 Market Facts & Figures by Type
7.3 Europe Metabotropic Glutamate Receptor 7 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Metabotropic Glutamate Receptor 7 by Region
8.1.1 Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Region
8.1.2 Asia Pacific Metabotropic Glutamate Receptor 7 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Metabotropic Glutamate Receptor 7 Market Facts & Figures by Type
8.3 Asia Pacific Metabotropic Glutamate Receptor 7 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Metabotropic Glutamate Receptor 7 by Country
9.1.1 Latin America Metabotropic Glutamate Receptor 7 Sales by Country
9.1.2 Latin America Metabotropic Glutamate Receptor 7 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Metabotropic Glutamate Receptor 7 Market Facts & Figures by Type
9.3 Central & South America Metabotropic Glutamate Receptor 7 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Metabotropic Glutamate Receptor 7 by Country
10.1.1 Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Country
10.1.2 Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Metabotropic Glutamate Receptor 7 Market Facts & Figures by Type
10.3 Middle East and Africa Metabotropic Glutamate Receptor 7 Market Facts & Figures by Application
11 Company Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Description and Business Overview
11.1.3 Addex Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Products Offered
11.1.5 Addex Therapeutics Ltd Related Developments
11.2 Aevi Genomic Medicine Inc
11.2.1 Aevi Genomic Medicine Inc Corporation Information
11.2.2 Aevi Genomic Medicine Inc Description and Business Overview
11.2.3 Aevi Genomic Medicine Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Products Offered
11.2.5 Aevi Genomic Medicine Inc Related Developments
11.3 Bio-Pharm Solutions Co Ltd
11.3.1 Bio-Pharm Solutions Co Ltd Corporation Information
11.3.2 Bio-Pharm Solutions Co Ltd Description and Business Overview
11.3.3 Bio-Pharm Solutions Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Products Offered
11.3.5 Bio-Pharm Solutions Co Ltd Related Developments
11.4 Pragma Therapeutics SAS
11.4.1 Pragma Therapeutics SAS Corporation Information
11.4.2 Pragma Therapeutics SAS Description and Business Overview
11.4.3 Pragma Therapeutics SAS Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Products Offered
11.4.5 Pragma Therapeutics SAS Related Developments
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Description and Business Overview
11.1.3 Addex Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Products Offered
11.1.5 Addex Therapeutics Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Metabotropic Glutamate Receptor 7 Market Estimates and Projections by Region
12.1.1 Global Metabotropic Glutamate Receptor 7 Sales Forecast by Regions 2021-2026
12.1.2 Global Metabotropic Glutamate Receptor 7 Revenue Forecast by Regions 2021-2026
12.2 North America Metabotropic Glutamate Receptor 7 Market Size Forecast (2021-2026)
12.2.1 North America: Metabotropic Glutamate Receptor 7 Sales Forecast (2021-2026)
12.2.2 North America: Metabotropic Glutamate Receptor 7 Revenue Forecast (2021-2026)
12.2.3 North America: Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2021-2026)
12.3 Europe Metabotropic Glutamate Receptor 7 Market Size Forecast (2021-2026)
12.3.1 Europe: Metabotropic Glutamate Receptor 7 Sales Forecast (2021-2026)
12.3.2 Europe: Metabotropic Glutamate Receptor 7 Revenue Forecast (2021-2026)
12.3.3 Europe: Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Metabotropic Glutamate Receptor 7 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Metabotropic Glutamate Receptor 7 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Metabotropic Glutamate Receptor 7 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Metabotropic Glutamate Receptor 7 Market Size Forecast by Region (2021-2026)
12.5 Latin America Metabotropic Glutamate Receptor 7 Market Size Forecast (2021-2026)
12.5.1 Latin America: Metabotropic Glutamate Receptor 7 Sales Forecast (2021-2026)
12.5.2 Latin America: Metabotropic Glutamate Receptor 7 Revenue Forecast (2021-2026)
12.5.3 Latin America: Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Metabotropic Glutamate Receptor 7 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Metabotropic Glutamate Receptor 7 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Metabotropic Glutamate Receptor 7 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Metabotropic Glutamate Receptor 7 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Metabotropic Glutamate Receptor 7 Market Segments
Table 2. Ranking of Global Top Metabotropic Glutamate Receptor 7 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of JBPOS-0101
Table 5. Major Manufacturers of PGT-117
Table 6. Major Manufacturers of ADX-71743
Table 7. Major Manufacturers of Others
Table 8. Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Metabotropic Glutamate Receptor 7 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Metabotropic Glutamate Receptor 7 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Regions (2015-2020)
Table 12. Global Metabotropic Glutamate Receptor 7 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Metabotropic Glutamate Receptor 7 Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Metabotropic Glutamate Receptor 7 Sales Share by Manufacturers (2015-2020)
Table 15. Global Metabotropic Glutamate Receptor 7 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Metabotropic Glutamate Receptor 7 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabotropic Glutamate Receptor 7 as of 2019)
Table 17. Metabotropic Glutamate Receptor 7 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Metabotropic Glutamate Receptor 7 Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Metabotropic Glutamate Receptor 7 Price (2015-2020) (USD/Pcs)
Table 20. Metabotropic Glutamate Receptor 7 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Metabotropic Glutamate Receptor 7 Product Type
Table 22. Date of International Manufacturers Enter into Metabotropic Glutamate Receptor 7 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Metabotropic Glutamate Receptor 7 Sales by Type (2015-2020) (K Pcs)
Table 25. Global Metabotropic Glutamate Receptor 7 Sales Share by Type (2015-2020)
Table 26. Global Metabotropic Glutamate Receptor 7 Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Metabotropic Glutamate Receptor 7 Revenue Share by Type (2015-2020)
Table 28. Metabotropic Glutamate Receptor 7 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Metabotropic Glutamate Receptor 7 Sales by Application (2015-2020) (K Pcs)
Table 30. Global Metabotropic Glutamate Receptor 7 Sales Share by Application (2015-2020)
Table 31. North America Metabotropic Glutamate Receptor 7 Sales by Country (2015-2020) (K Pcs)
Table 32. North America Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2015-2020)
Table 33. North America Metabotropic Glutamate Receptor 7 Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Metabotropic Glutamate Receptor 7 Revenue Market Share by Country (2015-2020)
Table 35. North America Metabotropic Glutamate Receptor 7 Sales by Type (2015-2020) (K Pcs)
Table 36. North America Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2015-2020)
Table 37. North America Metabotropic Glutamate Receptor 7 Sales by Application (2015-2020) (K Pcs)
Table 38. North America Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2015-2020)
Table 39. Europe Metabotropic Glutamate Receptor 7 Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2015-2020)
Table 41. Europe Metabotropic Glutamate Receptor 7 Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Metabotropic Glutamate Receptor 7 Revenue Market Share by Country (2015-2020)
Table 43. Europe Metabotropic Glutamate Receptor 7 Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2015-2020)
Table 45. Europe Metabotropic Glutamate Receptor 7 Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2015-2020)
Table 55. Latin America Metabotropic Glutamate Receptor 7 Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Metabotropic Glutamate Receptor 7 Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Metabotropic Glutamate Receptor 7 Revenue Market Share by Country (2015-2020)
Table 59. Latin America Metabotropic Glutamate Receptor 7 Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2015-2020)
Table 61. Latin America Metabotropic Glutamate Receptor 7 Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2015-2020)
Table 71. Addex Therapeutics Ltd Corporation Information
Table 72. Addex Therapeutics Ltd Description and Major Businesses
Table 73. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Addex Therapeutics Ltd Product
Table 75. Addex Therapeutics Ltd Recent Development
Table 76. Aevi Genomic Medicine Inc Corporation Information
Table 77. Aevi Genomic Medicine Inc Description and Major Businesses
Table 78. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Aevi Genomic Medicine Inc Product
Table 80. Aevi Genomic Medicine Inc Recent Development
Table 81. Bio-Pharm Solutions Co Ltd Corporation Information
Table 82. Bio-Pharm Solutions Co Ltd Description and Major Businesses
Table 83. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Bio-Pharm Solutions Co Ltd Product
Table 85. Bio-Pharm Solutions Co Ltd Recent Development
Table 86. Pragma Therapeutics SAS Corporation Information
Table 87. Pragma Therapeutics SAS Description and Major Businesses
Table 88. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Pragma Therapeutics SAS Product
Table 90. Pragma Therapeutics SAS Recent Development
Table 91. Global Metabotropic Glutamate Receptor 7 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 92. Global Metabotropic Glutamate Receptor 7 Sales Market Share Forecast by Regions (2021-2026)
Table 93. Global Metabotropic Glutamate Receptor 7 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 94. Global Metabotropic Glutamate Receptor 7 Revenue Market Share Forecast by Regions (2021-2026)
Table 95. North America: Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 96. North America: Metabotropic Glutamate Receptor 7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Europe: Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 98. Europe: Metabotropic Glutamate Receptor 7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Asia Pacific: Metabotropic Glutamate Receptor 7 Sales Forecast by Region (2021-2026) (K Pcs)
Table 100. Asia Pacific: Metabotropic Glutamate Receptor 7 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 101. Latin America: Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. Latin America: Metabotropic Glutamate Receptor 7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Middle East and Africa: Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Middle East and Africa: Metabotropic Glutamate Receptor 7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 106. Key Challenges
Table 107. Market Risks
Table 108. Main Points Interviewed from Key Metabotropic Glutamate Receptor 7 Players
Table 109. Metabotropic Glutamate Receptor 7 Customers List
Table 110. Metabotropic Glutamate Receptor 7 Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Metabotropic Glutamate Receptor 7 Product Picture
Figure 2. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type in 2020 & 2026
Figure 3. JBPOS-0101 Product Picture
Figure 4. PGT-117 Product Picture
Figure 5. ADX-71743 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application in 2020 & 2026
Figure 8. Generalized Anxiety Disorder
Figure 9. Infantile Spasm
Figure 10. Status Epilepticus
Figure 11. Others
Figure 12. Metabotropic Glutamate Receptor 7 Report Years Considered
Figure 13. Global Metabotropic Glutamate Receptor 7 Market Size 2015-2026 (US$ Million)
Figure 14. Global Metabotropic Glutamate Receptor 7 Sales 2015-2026 (K Pcs)
Figure 15. Global Metabotropic Glutamate Receptor 7 Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2015-2020)
Figure 17. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Region in 2019
Figure 18. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Region (2015-2020)
Figure 19. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Region in 2019
Figure 20. Global Metabotropic Glutamate Receptor 7 Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Metabotropic Glutamate Receptor 7 Revenue in 2019
Figure 22. Metabotropic Glutamate Receptor 7 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2015-2020)
Figure 24. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type in 2019
Figure 25. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2015-2020)
Figure 26. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Type in 2019
Figure 27. Global Metabotropic Glutamate Receptor 7 Market Share by Price Range (2015-2020)
Figure 28. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2015-2020)
Figure 29. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application in 2019
Figure 30. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2015-2020)
Figure 31. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application in 2019
Figure 32. North America Metabotropic Glutamate Receptor 7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Metabotropic Glutamate Receptor 7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Metabotropic Glutamate Receptor 7 Sales Market Share by Country in 2019
Figure 35. North America Metabotropic Glutamate Receptor 7 Revenue Market Share by Country in 2019
Figure 36. U.S. Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Metabotropic Glutamate Receptor 7 Market Share by Type in 2019
Figure 41. North America Metabotropic Glutamate Receptor 7 Market Share by Application in 2019
Figure 42. Europe Metabotropic Glutamate Receptor 7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Metabotropic Glutamate Receptor 7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Country in 2019
Figure 45. Europe Metabotropic Glutamate Receptor 7 Revenue Market Share by Country in 2019
Figure 46. Germany Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Metabotropic Glutamate Receptor 7 Market Share by Type in 2019
Figure 57. Europe Metabotropic Glutamate Receptor 7 Market Share by Application in 2019
Figure 58. Asia Pacific Metabotropic Glutamate Receptor 7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Metabotropic Glutamate Receptor 7 Sales Market Share by Region in 2019
Figure 61. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue Market Share by Region in 2019
Figure 62. China Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Metabotropic Glutamate Receptor 7 Market Share by Type in 2019
Figure 85. Asia Pacific Metabotropic Glutamate Receptor 7 Market Share by Application in 2019
Figure 86. Latin America Metabotropic Glutamate Receptor 7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Metabotropic Glutamate Receptor 7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share by Country in 2019
Figure 89. Latin America Metabotropic Glutamate Receptor 7 Revenue Market Share by Country in 2019
Figure 90. Mexico Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Metabotropic Glutamate Receptor 7 Market Share by Type in 2019
Figure 97. Latin America Metabotropic Glutamate Receptor 7 Market Share by Application in 2019
Figure 98. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue Market Share by Country in 2019
Figure 102. Turkey Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Metabotropic Glutamate Receptor 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Metabotropic Glutamate Receptor 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Metabotropic Glutamate Receptor 7 Market Share by Type in 2019
Figure 109. Middle East and Africa Metabotropic Glutamate Receptor 7 Market Share by Application in 2019
Figure 110. North America Metabotropic Glutamate Receptor 7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Metabotropic Glutamate Receptor 7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Metabotropic Glutamate Receptor 7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Metabotropic Glutamate Receptor 7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Metabotropic Glutamate Receptor 7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Metabotropic Glutamate Receptor 7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Metabotropic Glutamate Receptor 7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
代謝型グルタミン酸受容体5の世界市場（～2026年） Market Analysis and Insights: Global Metabotropic Glutamate Receptor 5 Market The global Metabotropic Glutamate Receptor 5 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Metabotropic Glutamate Receptor 5 Scope and Mar…- グルタミン酸ナトリウムの世界市場（～2026年） Sodium glutamate commonly referred as MSG, also known as monosodium glutamate is sodium salt of glutamic acid. Sodium glutamate is available in the market through various trade names such as third spice, accent, ajinomoto and vetsin among others. The market for sodium glutamate was mainly driven by …
- グルタミン酸カルボキシペプチダーゼ2の世界市場（～2026年） Market Analysis and Insights: Global Glutamate Carboxypeptidase 2 Market The global Glutamate Carboxypeptidase 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glutamate Carboxypeptidase 2 Scope and Market Size Glutam…
- グルタメート界面活性剤の世界市場（～2026年） Market Analysis and Insights: Global Glutamate Surfactants Market The global Glutamate Surfactants market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glutamate Surfactants Scope and Market Size Glutamate Surfactants marke…
- グルタミン酸・グルタミン酸ナトリウムの世界市場（～2026年） Market Analysis and Insights: Global Glutamic Acid and Monosodium Glutamate Market The global Glutamic Acid and Monosodium Glutamate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glutamic Acid and Monosodium Glutamat…